American Fusion(TM) Inc. (AMFN) Showcases Texatron(TM)

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
80
American Fusion(TM) Inc. (AMFN) Showcases Texatron(TM) Development Program at Major US Physics Conference


- The company presented its Texatron(TM) Fusion Engine(TM) development program and related scientific research at the American Physical Society Division of Particles and Fields 2026 Meeting held at Fermilab.

- Chief Technology Officer Dr. John E. Brandenburg outlined the company’s Texatron(TM) development efforts alongside his Gravity-Electromagnetic (“GEM”) Unification Theory.

- The company continues to develop the Texatron(TM) Fusion Engine(TM) through its wholly owned subsidiary, Kepler Fusion Technologies, with a focus on modular fusion energy systems.

- American Fusion(TM) believes the theoretical plasma physics concepts presented may complement the ongoing engineering development of the Texatron(TM) platform, although the GEM theory remains subject to continued scientific evaluation.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, has taken another step in advancing the visibility of its fusion energy research, with Chief Technology Officer Dr. John E. Brandenburg presenting the company’s Texatron(TM) Fusion Engine(TM) development program during one of the leading scientific conferences for particle physics.

The presentation took place at the American Physical Society (“APS”) Division of Particles and Fields (“DPF”) 2026 Meeting, hosted at the U.S. Department of Energy’s Fermi National Accelerator Laboratory (“Fermilab”) in Batavia, Illinois. The biennial conference brings together researchers from national laboratories, universities, and research institutions, to discuss developments in particle physics and related fields (https://nnw.fm/hRKFP).

Alongside an introductory overview of the Texatron(TM) Fusion Engine(TM) program, Dr. Brandenburg presented his Gravity-Electromagnetic (“GEM”) Unification Theory, a theoretical framework that proposes a first-principles mathematical derivation of Newton’s gravitational constant. According to the company, the presentation explored how gravity, electromagnetism, plasma physics, and quantum mechanics, may all be connected within a unified analytical framework.

The GEM theory proposes that Newton’s gravitational constant is not simply an experimentally measured value but emerges from the physical conditions believed to have existed in the early universe. The presentation also discussed the incorporation of quantum mechanics into the model through the fine-structure constant and examined mathematical relationships associated with hydrogen plasma.

While the GEM framework remains a theoretical model requiring continued scientific evaluation, American Fusion(TM) said it believes aspects of the plasma physics discussed could complement future theoretical work supporting the engineering development of the Texatron(TM) Fusion Engine(TM). The company emphasized that its fusion program continues to be driven by experimental validation and ongoing research.

According to the company, the presentation generated substantial audience participation, with attendees posing technical questions regarding the GEM framework and its underlying assumptions. Management characterized the discussion as part of its broader commitment to scientific dialogue and peer engagement as development of the Texatron(TM) platform continues.

“Presenting the Texatron(TM) development program and Dr. Brandenburg’s GEM Unification Theory before one of the world’s premier particle physics communities reflects our commitment to advancing scientific dialogue through rigorous analysis, constructive technical discussion, experimental validation, and peer engagement,” commented Executive Chairman Brent Nelson. “We congratulate Dr. Brandenburg on an outstanding presentation and look forward to continuing our research and development efforts as the Texatron(TM) program advances.”

American Fusion(TM) is developing its fusion technology through its wholly owned subsidiary, Kepler Fusion Technologies. Unlike conventional large-scale fusion concepts requiring centralized facilities, the Texatron(TM) Fusion Engine(TM) is being designed as a modular platform capable of deployment across multiple end markets. Management has previously outlined commercial opportunities that include data centers, industrial facilities, mining operations, defense applications and locations where electric grid capacity is constrained.

The company has also continued expanding its intellectual property portfolio as development progresses. Earlier this year, American Fusion(TM) announced additional U.S. patent filings covering various aspects of the Texatron(TM) platform, reflecting a strategy that combines engineering development with long-term protection of proprietary technologies.

Operationally, the company has continued advancing its testing program during 2026. Previous announcements described regulatory approvals supporting testing activities in Texas and outlined plans to evaluate multiple Texatron(TM) system configurations spanning power outputs from hundreds of kilowatts to multi-megawatt installations. Management has indicated that these efforts are intended to generate engineering data supporting future commercialization.

For more information, visit the company’s website at www.AmericanFusionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to AMFN are available in the company’s newsroom at https://nnw.fm/AMFN

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

American Fusion Inc (AMFN) Stock Research Links

AMFN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sarepta Therapeutics Faces Legal Scrutiny Amid Regulatory Challenges

Updated Category News Views 146

Legal Challenges for Sarepta Therapeutics The situation regarding Sarepta Therapeutics is becoming increasingly complex. Recently, a pending securities class action was initiated due to unsettling news about safety concerns linked to their medication, ELEVIDYS. This product aims to treat Duchenne muscular dystrophy, a severe condition affecting young boys. As the company...

Continue Reading
Enhancing Landscape Operations: LandCare's Partnership with Lytx+™

Updated Category News Views 81

LandCare Enhances Operational Efficiencies with Lytx+ LandCare, a leading commercial landscaping company in the nation, has made significant strides in its operations by adopting the innovative Lytx+™ solution in conjunction with Geotab. This collaboration aims to optimize fleet safety and management, ensuring that LandCare continues to thrive in a competitive...

Continue Reading
Grand Sierra Resort Launches Ambitious $1 Billion Arena Project

Updated Category News Views 292

Grand Sierra Resort Unveils Major Arena Development Grand Sierra Resort (GSR) has officially broken ground on a groundbreaking new arena, marking the first phase of an extensive $1 billion redevelopment project that is set to forever change the landscape of Reno. This ambitious undertaking is the largest private investment in the history of the region, signaling a bright...

Continue Reading
Saba Capital Management Adjusts Holdings in Eaton Vance Trust

Updated Category News Views 74

Saba Capital Management Modifies Its Holdings in Eaton Vance Trust Saba Capital Management, L.P., a significant player in the investment management sector, has recently garnered attention by adjusting its position in the Eaton Vance California Municipal Income Trust (NYSE: CEV). This strategic decision involved the sale of 44,367 shares, accumulating over $484,725 over...

Continue Reading
Key Insights on Treatt Plc's Market Dealing Activities

Updated Category News Views 127

Understanding the Amendment for Treatt Plc The recent amendment related to Treatt Plc has sparked interest in financial circles, especially among shareholders and market analysts. This document outlines public dealing disclosures from an exempt principal trader acting on behalf of a clientele, primarily concerning Treatt Plc, a prominent player in the flavor and fragrance...

Continue Reading